van Hoogstraten, L. M. et al. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat. Rev. Clin. Oncol. 20, 287–304 (2023).
Kim, J.-S., Lee, J., Nguyen, T. T. & Choi, S. Y. Optimal timing for the first cystoscopic follow-up using time-to-treatment initiation analysis of oncologic outcomes in primary non-muscle invasive bladder cancer. Sci. Rep. 14, 8440 (2024).
Mossanen, M. & Gore, J. L. The burden of bladder cancer care: direct and indirect costs. Curr. Opin. Urol. 24, 487–491 (2014).
Sievert, K. D. et al. Economic aspects of bladder cancer: what are the benefits and costs? World J. Urol. 27, 295–300 (2009).
Tan, W. S., Rodney, S., Lamb, B., Feneley, M. & Kelly, J. Management of non-muscle invasive bladder cancer: a comprehensive analysis of guidelines from the United States, Europe and Asia. Cancer Treat. Rev. 47, 22–31 (2016).
Grabe-Heyne, K. et al. Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs. Front. Oncol. 13, 1170124 (2023).
Holzbeierlein, J. M. et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline: 2024 amendment. J. Urol. 211, 533–538 (2024).
Shkolyar, E. et al. Optimizing cystoscopy and TURBT: enhanced imaging and artificial intelligence. Nat. Rev. Urol. 22, 46–54 (2025).
Maas, M., Todenhöfer, T. & Black, P. C. Urine biomarkers in bladder cancer—current status and future perspectives. Nat. Rev. Urol. 20, 597–614 (2023).
Ng, K., Stenzl, A., Sharma, A. & Vasdev, N. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. Urologic Oncology: Seminars and Original Investigations 39, 41–51 (2021).
Thomas, C. E., Sexton, W., Benson, K., Sutphen, R. & Koomen, J. Urine collection and processing for protein biomarker discovery and quantification. Cancer Epidemiol. Biomark. Prev. 19, 953–959 (2010).
Lee, S., Oh, J., Cho, M. & Kim, J. K. Fluorescence-based microendoscopic sensing system for minimally invasive in vivo bladder cancer diagnosis. Biosensors 12, 631 (2022).
Witjes, J. A. et al. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations. Eur. Urol. 66, 863–871 (2014).
Alchera, E. et al. Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods. Photoacoustics 28, 100400 (2022).
Sim, K. C. & Sung, D. J. Role of magnetic resonance imaging in tumor staging and follow-up for bladder cancer. Transl. Androl. Urol. 9, 2890 (2020).
Simó, C. et al. Urease-powered nanobots for radionuclide bladder cancer therapy. Nat. Nanotechnol. 19, 554–564 (2024).
Hafeez, S. & Huddart, R. Advances in bladder cancer imaging. BMC Med. 11, 1–10 (2013).
Kwong, G. A. et al. Synthetic biomarkers: a twenty-first century path to early cancer detection. Nat. Rev. Cancer 21, 655–668 (2021).
Joice, G. A., Bivalacqua, T. J. & Kates, M. Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer. Nat. Rev. Urol. 16, 599–612 (2019).
Sweeney, S. K., Luo, Y., O’Donnell, M. A. & Assouline, J. Nanotechnology and cancer: improving real-time monitoring and staging of bladder cancer with multimodal mesoporous silica nanoparticles. Cancer Nanotechnol. 7, 1–18 (2016).
Wu, D. et al. Sensitive electrochemical immunosensor for detection of nuclear matrix protein-22 based on NH2-SAPO-34 supported Pd/Co nanoparticles. Sci. Rep. 6, 24551 (2016).
Liang, L.-G. et al. An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer. Sci. Rep. 7, 1–10 (2017).
Peng, C. et al. A colorimetric immunosensor based on self-linkable dual-nanozyme for ultrasensitive bladder cancer diagnosis and prognosis monitoring. Biosens. Bioelectron. 126, 581–589 (2019).
Tomiyama, E. et al. EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer. Br. J. Cancer 127, 1312–1323 (2022).
Feng, Y. et al. Iodide-enhanced perovskite nanozyme-based colorimetric platform for detection of urinary nuclear matrix protein 22. ACS Appl. Mater. Interfaces 15, 27742–27749 (2023).
Li, Q. et al. Choline phosphate-grafted nanozymes as universal extracellular vesicle probes for bladder cancer detection. ACS Nano 18, 16113–16125 (2024).
Song, F.-X. et al. Recent progress in nanomaterial-based biosensors and theranostic nanomedicine for bladder cancer. Biosensors 13, 106 (2023).
Hao, L. et al. Microenvironment-triggered multimodal precision diagnostics. Nat. Mater. 20, 1440–1448 (2021).
Landry, M. P. et al. Single-molecule detection of protein efflux from microorganisms using fluorescent single-walled carbon nanotube sensor arrays. Nat. Nanotechnol. 12, 368–377 (2017).
Zhang, Y., Li, M., Gao, X., Chen, Y. & Liu, T. Nanotechnology in cancer diagnosis: progress, challenges and opportunities. J. Hematol. Oncol. 12, 1–13 (2019).
Hao, L. et al. CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics. Nat. Nanotechnol. 18, 798–807 (2023).
Kim, M. et al. Detection of ovarian cancer via the spectral fingerprinting of quantum-defect-modified carbon nanotubes in serum by machine learning. Nat. Biomed. Eng. 6, 267–275 (2022).
Lukacz, E. S. et al. A healthy bladder: a consensus statement. Int. J. Clin. Pract. 65, 1026–1036 (2011).
Machado, M., Yim, W. & Strano, M. S. A sensor solution to the femtomolar problem in bladder cancer. ACS Sens. 10, 6501–6511 (2025).
Erickson, H. P. Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy. Biol. Proced. Online 11, 32–51 (2009).
Zheng, Z., Wan, Q., Meixiong, G. & Du, Q. Cell cycle–regulated membrane binding of NuMA contributes to efficient anaphase chromosome separation. Mol. Biol. Cell 25, 606–619 (2014).
Kotak, S., Busso, C. & Gönczy, P. NuMA interacts with phosphoinositides and links the mitotic spindle with the plasma membrane. EMBO J. 33, 1815–1830 (2014).
Wang, W., Ji, X., Kapur, A., Zhang, C. & Mattoussi, H. A multifunctional polymer combining the imidazole and zwitterion motifs as a biocompatible compact coating for quantum dots. JACS 137, 14158–14172 (2015).
Silmore, K. S., Gong, X., Strano, M. S. & Swan, J. W. High-resolution nanoparticle sizing with maximum a posteriori nanoparticle tracking analysis. ACS Nano 13, 3940–3952 (2019).
Park, M. et al. Measuring the accessible surface area within the nanoparticle corona using molecular probe adsorption. Nano Lett. 19, 7712–7724 (2019).
Sánchez-Velázquez, G. et al. Using molecular probe adsorption to characterize the nanoparticle corona phase and molecular recognition. Langmuir 41, 17602–17614 (2025).
Miyake, M. et al. Influencing factors on the NMP-22 urine assay: an experimental model. BMC Urol. 12, 1–6 (2012).
Jamshidian, H., Kor, K. & Djalali, M. Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder. Urol J. 5, 243–247 (2008).
Messing, E. M. et al. Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non-muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial. JAMA 319, 1880–1888 (2018).
Cho, S.-Y. et al. Cellular lensing and near infrared fluorescent nanosensor arrays to enable chemical efflux cytometry. Nat. Commun. 12, 3079 (2021).
Wu, D. et al. Phenolic-enabled nanotechnology: versatile particle engineering for biomedicine. Chem. Soc. Rev. 50, 4432–4483 (2021).
Kitazaki, S., Tanaka, A. & Hayashi, N. Sterilization of narrow tube inner surface using discharge plasma, ozone, and UV light irradiation. Vacuum 110, 217–220 (2014).
John, J. et al. The porcine model for urological research and training: an endoscopic and CT-based study. Uro 6, 7 (2026).
Jin, Z. et al. Modification of poly(maleic anhydride)-based polymers with H2N–R nucleophiles: addition or substitution reaction? Bioconjugate Chem. 30, 871–880 (2019).
Zhang, J. et al. Molecular recognition using corona phase complexes made of synthetic polymers adsorbed on carbon nanotubes. Nat. Nanotechnol. 8, 959–968 (2013).
Yim, W. et al. Polyphenol-stabilized coacervates for enzyme-triggered drug delivery. Nat. Commun. 15, 7295 (2024).
Kilani, R. et al. Selective cytotoxicity of gemcitabine in bladder cancer cell lines. Anti-Cancer Drugs 13, 557–566 (2002).